 |
|
|
| |
COMPARISON OF VIRAL REPLICATION FOR THE
2-DRUG REGIMEN (2DR) OF DOLUTEGRAVIR/LAMIVUDINE (DTG/3TC) VERSUS A 3/4-DRUG TENOFOVIR ALAFENAMIDE-BASED REGIMEN (TBR) IN THE TANGO STUDY THROUGH WEEK 96
|
| |
| |
IAS 2021 July 18-22
Ruolan Wang,1 Jonathan Wright,2 Nisha George,2 Mounir Ait-Khaled,3 Thomas Lutz,4 Olayemi Osiyemi,5 Miguel Gorgolas,6 Peter Leone,1 Brian Wynne,1 Jean Andre van Wyk,3 Mark Underwood1
1ViiV Healthcare, Research Triangle Park, NC, USA; 2GlaxoSmithKline, Brentford, UK; 3ViiV Healthcare, Brentford, UK; 4Infektio Research, Frankfurt, Germany; 5Triple O Research Institute PA, West Palm Beach, FL, USA; 6Jiménez Díaz Foundation University Hospital, Madrid, Spain
|
| |
|
|
|
|
|
